Abstract Objective To compare the efficacy of different statin treatments by intensity on levels of non-high density lipoprotein cholesterol (non-HDL-C) for the prevention of cardiovascular disease in people with diabetes. Design Systematic review and network meta-analysis. Data sources Medline, Cochrane Central Register of Controlled Trials, and Embase from inception to 1 December 2021 Continue reading →

Acumen Research and Consulting Acumen Research and Consulting recently published report titled Anastomosis Devices Market - Global Industry Analysis, Market Size, Opportunities and Forecast, 2021-2028 NEW YORK, March 28, 2022 (GLOBE NEWSWIRE) -- The global anastomosis devices market size is estimated to grow a CAGR above 7.1% over the forecast timeframe and reach a market value of around USD 3,822 million by 2028. Continue reading →

JAMA Netw Open. 2022 Mar 1;5(3):e223849. Continue reading →

Millions of people in the UK and around the world spend many years of their later life in poor health. Our Future Health aims to tackle this and help people live healthier lives for longer by creating the UKs largest ever health research programme to prevent, detect and treat diseases Continue reading →

The new report by Expert Market Research titled, Global Heparin Market Size, Share, Price, Trends, Growth, Report and Forecast 2021-2026, gives an in-depth analysis of the globalheparin market, assessing the market based on its segments like application, route of administration, end-use, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market Continue reading →

AWANS, Belgium, March 29, 2022 /PRNewswire/ -- Miracor Medical SA (Miracor Medical) today announced the first patient enrolled in the PICSO-AMI-V study to evaluate the benefits of PiCSO (Pressure Controlled Intermittent Coronary Sinus Occlusion) therapy as an adjunct to conventional primary percutaneous coronary intervention (PCI) for patients presenting with inferior ST-Elevation Myocardial Infarction (STEMI). "Improving outcomes for patients with large heart attacks remains an important unmet need." The first patient enrolled was treated at the University Hospital of Toulouse, France by the team of Professor Didier Carri (Drs T Continue reading →